These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16234588)

  • 1. Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma.
    Dvalishvili I; Charkviani L; Charkviani T; Turashvili G; Burkadze G
    Georgian Med News; 2005 Sep; (126):27-31. PubMed ID: 16234588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of cadherin e and clinical prognostic factors in uterine endometrioid adenocarcinoma.
    Dvalishvili I; Charkviani L; Turashvili G; Burkadze G
    Georgian Med News; 2005 Nov; (128):17-21. PubMed ID: 16369055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of prognostic factors in uterine endometrioid adenocarcinoma of various grade.
    Dvalishvili I; Charkviani L; Turashvili G; Burkadze G
    Georgian Med News; 2006 Mar; (132):24-7. PubMed ID: 16636372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
    Stefansson IM; Salvesen HB; Immervoll H; Akslen LA
    Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
    Murray SK; Young RH; Scully RE
    Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
    An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
    Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.
    Nazeer T; Church K; Amato C; Ambros RA; Rosano TG; Malfetano JH; Ross JS
    Mod Pathol; 1994 May; 7(4):469-74. PubMed ID: 8066075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium.
    Stewart CJ; Crook ML; Lacey J; Louwen K
    Int J Gynecol Pathol; 2011 Sep; 30(5):484-91. PubMed ID: 21804393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer.
    Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ
    Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
    Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
    Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study.
    Saygili U; Koyuncuoglu M; Altunyurt S; Guclu S; Uslu T; Erten O
    Gynecol Oncol; 2001 Oct; 83(1):20-4. PubMed ID: 11585409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
    Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
    Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma.
    Talvensaari-Mattila A; Santala M; Soini Y; Turpeenniemi-Hujanen T
    Anticancer Res; 2005; 25(6B):4101-5. PubMed ID: 16309203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
    Stokes GN; Shelton JB; Zahn CM; Kendall BS
    Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.
    Mylonas I; Mayr D; Walzel H; Shabani N; Dian D; Kuhn C; Kunze S; Jeschke U; Friese K
    Anticancer Res; 2007; 27(4A):1975-80. PubMed ID: 17649808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical profile of endometrioid adenocarcinoma of the uterus: ER, PR, HER-2, Ki-67 and their prognostic value].
    Pozharisskiĭ KM; Samsonova EA; Ten VP; Maksimova NA; Urmancheeva AF
    Arkh Patol; 2005; 67(2):13-7. PubMed ID: 15938112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
    Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression levels of adiponectin receptors are decreased in human endometrial adenocarcinoma tissues.
    Yamauchi N; Takazawa Y; Maeda D; Hibiya T; Tanaka M; Iwabu M; Okada-Iwabu M; Yamauchi T; Kadowaki T; Fukayama M
    Int J Gynecol Pathol; 2012 Jul; 31(4):352-7. PubMed ID: 22653349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.